| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 09/24/2009 | US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 09/24/2009 | US20090240015 Diol (meth) acrylate compound having urethane bond, method for producing the same, and polymer thereof |
| 09/24/2009 | US20090239944 Novel Use of Organic Compounds |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1214944B1 Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity |
| 09/23/2009 | CN101541777A Ketomethionine ketals and their derivatives |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/17/2009 | US20090234141 Process for producing vinylene carbonate |
| 09/17/2009 | US20090233952 Substituted cycloalkene derivative |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2099790A2 Process for preparing nebivolol |
| 09/16/2009 | EP2099751A1 Biphenyl-substituted spirocyclic ketoenols |
| 09/16/2009 | CN101531579A Diaromatic compound with bioactivity |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589089 Inhibitors for GlyT-1 |
| 09/15/2009 | CA2288854C Novel indanylidene compounds |
| 09/11/2009 | WO2009110609A1 Method for producing phosphoroamide compound, method for producing complex, and method for producing optically active alcohol |
| 09/11/2009 | WO2009109765A1 Synthesis of cyclic carbonates |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/09/2009 | EP1567477B1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/09/2009 | CN101525329A Synthetic method of glycerin methylal |
| 09/09/2009 | CN100537585C Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/08/2009 | US7586008 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient |
| 09/08/2009 | US7585995 Continuous wasteless ecologically safe technology of propylenecarbonate production in presence of phthalocyanine catalysts |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/03/2009 | WO2009107449A1 Method for producing fluorinated 1,3-dioxolan-2-one |
| 09/03/2009 | WO2009106605A1 Membrane separation method for separating high boiler during the production of 1,3-dioxolane-2-ones |
| 09/03/2009 | WO2009047613A3 An improved process for the preparation of tadalafil intermediate |
| 09/03/2009 | US20090221840 Process for purifying ethylene carbonate, process for producing purified ethylene carbonate, and ethylene carbonate |
| 09/03/2009 | US20090221811 Process for preparing gemcitabine and associated intermediates |
| 09/03/2009 | US20090221529 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | CA2715313A1 Membrane separation method for separating high boiler during the production of 1,3-dioxolane-2-ones |
| 09/02/2009 | EP2094679A2 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 09/02/2009 | EP2094656A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 09/02/2009 | EP1758852B1 Substituted cyclopentene compounds |
| 09/02/2009 | CN101522657A STAT3/5 activation inhibitor |
| 09/02/2009 | CN101519398A Preparation of 4-fluoro-1,3-dioxolane-2-one |
| 09/02/2009 | CN101519397A Method for preparing a 1,3-dioxolane compound |
| 09/01/2009 | USRE40901 14- Beta -hydroxy-1,14-carbonate-baccatine III and V derivatives, 13-substituted by an isoserine residue; remarkable cytotoxic and anticarcinogenic-agent activities; capable of overcoming the resistance of cell lines expressing the multidrug resistant phenotype; breast, ovarian, colon cancers |
| 09/01/2009 | US7582766 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; (N-benzyl)phenylacetamides or N-benzyl-N'-phenyl ureas |
| 09/01/2009 | US7582714 Optical/electrical material; photoresists |
| 09/01/2009 | CA2510394C Decahydronaphthalene derivative |
| 09/01/2009 | CA2256941C Process for the alkylation of alkyl- or benzylcyanogen derivatives in the presence of trialkylamines or -phosphines |
| 08/27/2009 | US20090216009 Process for the production of ezetimibe and intermediates used in this process |
| 08/26/2009 | EP2091934A1 Ketomethionine ketals and their derivatives |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP1904470B1 S-indacene- and indeno[5,6-d][1,3]dioxol-derivatives and use thereof as components of liquid-crystal mixtures |
| 08/26/2009 | CN101516866A Method of production of enantiomer-enriched alkylene carbonates |
| 08/26/2009 | CN101514195A Preparation method for cyclic carbonates |
| 08/25/2009 | US7579500 Reacting xylene with chloroacetyl chloride forming 2-chloro-1-(2,5-dimethylphenyl)ethanone; rearrangement; hydrolysis |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/20/2009 | US20090208427 Vanillin Acetals and Sensory Stimulant Composition Containing the Same |
| 08/20/2009 | US20090208426 Use of Diacetyl Trimer as an Aromatic and Flavouring Substance |
| 08/19/2009 | EP2090574A1 Method for preparing stiripentol particles with defined particle size |
| 08/19/2009 | EP2090566A2 Certain phenylacetic acids and derivatives |
| 08/19/2009 | EP2089373A1 Stat3/5 activation inhibitor |
| 08/19/2009 | CN101511822A Modulators of chemokine receptor activity, crystalline forms and process |
| 08/19/2009 | CN101511810A Process for the preparation of alkylene carbonate |
| 08/19/2009 | CN100528858C Process for synthesising heliotropine and its derivatives |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576125 Piperonyl alcohol; storage stability |
| 08/18/2009 | US7576088 Benzodioxole derivatives |
| 08/13/2009 | WO2009071528A3 New process for the synthesis of moguisteine |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203774 Substituted benzyl ester derivative and use thereof |
| 08/13/2009 | US20090203773 Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X |
| 08/13/2009 | US20090202662 Treatment of erectile dysfunction and libido enhancement |
| 08/12/2009 | CN101506140A Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/12/2009 | CN101506134A Process for production of benzaldehyde co.mpound |
| 08/12/2009 | CN101503401A Chloric biphenyl cyclooctene lignan compounds and preparation thereof |
| 08/12/2009 | CN101503373A 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 08/12/2009 | CN101503341A Novel technique for preparing schizandrol A and schizandrol B |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/06/2009 | US20090198073 Preparation of phthalic anhydride by gas phase oxidation of o-xylene |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090197924 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 08/05/2009 | CN101497597A Preparation of 1,2-dialkyl-1,2-difluorinated ethylene carbonate |
| 08/05/2009 | CN101497596A Method for synthesizing diethyleno dioxide |
| 08/05/2009 | CN100524935C Organic electrolytic solution and lithium battery using the same |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522909C Reaction products of 2-propylheptanol with 1-halogen-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569676 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 08/04/2009 | US7569576 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 07/30/2009 | US20090192217 Method and composition for treating acne using lignan compounds |